Berahyaluronidase Alfa
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Berahyaluronidase Alfa, covering 2026-02-09 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Study of Pembrolizumab (+) Berahyaluronidase Alfa (MK-3475A) to Treat Newly-diagnosed Metastatic Non-small Cell Lung Cancer (MK-3475A-F84) [Phase 3]